当前位置: 首页 > 详情页

Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Senile Neurology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, PR China [b]Department of Anti-Ageing, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, PR China [c]Department of KI-Alzheimer Disease Research Center, Karolinska Institutet, Stockholm, 14186, Sweden [d]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, 100053, PR China [e]Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, 100053, PR China
出处:
ISSN:

关键词: Lycopene Insulin resistance Oxidative damage Neuroinflammation Cognitive deficits

摘要:
Fructose intake is linked with the increasing prevalence of insulin resistance, and insulin resistance links Alzheimer's disease with impaired insulin signaling, oxidative damage, neuroinflammation, and cognitive impairment. As a member of the carotenoid family of phytochemicals, lycopene is used as a potent free scavenger, and has been demonstrated to be effective in anti-oxidative stress and anti-inflammatory reaction in the models of AD and other neurodegenerative diseases. Here, we investigated the effect of lycopene on learning and memory impairment and the possible underlying molecular events in fructose-drinking insulin resistant rats. We found that long-term fructose-drinking causes insulin resistance, impaired insulin signaling, oxidative stress, neuroinflammation, down-regulated activity of cholinergic system, and cognitive impairment, which could be significantly ameliorated by oral lycopene administration. The results from this study provide experimental evidence for using lycopene in the treatment of brain damage caused by fructose-drinking insulin resistance. (C) 2014 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 2 区 医学
小类 | 2 区 神经科学 2 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 神经科学
JCR分区:
出版当年[2012]版:
Q1 PHARMACOLOGY & PHARMACY Q2 NEUROSCIENCES
最新[2023]版:
Q1 NEUROSCIENCES Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [a]Department of Senile Neurology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, PR China
通讯作者:
通讯机构: [*1]Department of Senile Neurology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, PR China. [*2]Department of NVS, KI-Alzheimer Disease Research Center, Karolinska Institutet, Stockholm, 14186, Sweden.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17069 今日访问量:2 总访问量:918 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院